electroCore, Inc. (ECOR)
NASDAQ
Healthcare
Medical - Devices
$6.09
▲ +0.66%
Market Cap
$50.5M
Sector
Healthcare
Industry
Medical - Devices
Beta
0.89
52-Wk Range
4.16-10.495
CEO
Thomas J. Errico
Country
US
Currency
USD
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquar…
Open full interactive analysis & DCF →